Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, Fiscus SA, Nelson JA, Eron JJ, Kumwenda J.

AIDS. 2009 Jun 1;23(9):1127-34. doi: 10.1097/QAD.0b013e32832ac34e.

2.

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.

Hosseinipour MC, Gupta RK, Van Zyl G, Eron JJ, Nachega JB.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S49-56. doi: 10.1093/infdis/jit107. Review.

4.

Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.

Humphreys EH, Chang LW, Harris J.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006517. doi: 10.1002/14651858.CD006517.pub3. Review.

PMID:
20556768
5.

Update on HIV-1 acquired and transmitted drug resistance in Africa.

Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, Ndembi N.

AIDS Rev. 2015 Jan-Mar;17(1):3-20. Review.

PMID:
25427100
6.

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.

Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, Hullsiek KH, Balduin M, Jakobsen MR, Geretti AM, Thiebaut R, Ostergaard L, Masquelier B, Johnson JA, Miller MD, Kuritzkes DR.

JAMA. 2011 Apr 6;305(13):1327-35. doi: 10.1001/jama.2011.375. Review.

7.

Drug resistance in HIV-1.

Kuritzkes DR.

Curr Opin Virol. 2011 Dec;1(6):582-9. doi: 10.1016/j.coviro.2011.10.020. Review.

8.

HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Shafer RW, Schapiro JM.

AIDS Rev. 2008 Apr-Jun;10(2):67-84. Review.

9.

Sequencing paediatric antiretroviral therapy in the context of a public health approach.

Boerma RS, Boender TS, van Hensbroek MB, Rinke de Wit TF, Sigaloff KC.

J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20265. doi: 10.7448/IAS.18.7.20265. eCollection 2015. Review.

10.

Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.

Souza SJ, Luzia LA, Santos SS, Rondó PH.

Rev Assoc Med Bras (1992). 2013 Mar-Apr;59(2):186-98. doi: 10.1016/j.ramb.2012.11.003. Review.

11.

The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.

Hong SY, Nachega JB, Kelley K, Bertagnolio S, Marconi VC, Jordan MR.

Infect Disord Drug Targets. 2011 Apr;11(2):124-33. Review.

12.

The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance.

Garforth SJ, Lwatula C, Prasad VR.

Viruses. 2014 Oct 23;6(10):4080-94. doi: 10.3390/v6104080. Review.

13.

Resistance assays.

Schutten M.

In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 5.

Items per page

Supplemental Content

Write to the Help Desk